Dyskeratosis Congenita - 25/06/18
Doi : 10.1016/S0733-8635(18)30104-9
Richard A. Drachtman, MD a, ⁎, Blanche P. Alter, MD b
a From the Division of Pediatric Hematology/Oncology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey
b The Division of Pediatric Hematology/Oncology, Department of Pediatrics, The University of Texas Medical Branch, Galveston, Texas
*Address reprint requests to: Richard A. Drachtman, MD, Division of Pediatric Hematology/Oncology, UMDNJ-Robert Wood Johnson Medical School, One Robert Wood Johnson Place, CN 19, New Brunswick, NJ 08903Division of Pediatric Hematology/OncologyUMDNJ-Robert Wood Johnson Medical SchoolOne Robert Wood Johnson Place, CN 19New BrunswickNJ08903
Résumé |
Dyskeratosis congenita is a rare genodermatosis. Malignant deterioration and hematologic complications are well-described features of this syndrome. Correct recognition is essential for proper management. A review of diagnostic considerations and treatment guidelines is presented.
Le texte complet de cet article est disponible en PDF.© 1995
Elsevier Inc. Tous droits réservés.
Vol 13 - N° 1
P. 33-39 - janvier 1995 Retour au numéro
Article précédent
- Cowden Syndrome (Multiple Hamartoma Syndrome)
- Susan Bayliss Mallory
- Fanconi Anemia
- Arleen D. Auerbach
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?